These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17273004

  • 1. Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9.
    Robertson AG, Davidson BR.
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):167-9. PubMed ID: 17273004
    [Abstract] [Full Text] [Related]

  • 2. [CA19-9 has no value as a tumor marker in obstructive jaundice].
    Peterli R, Meyer-Wyss B, Herzog U, Tondelli P.
    Schweiz Med Wochenschr; 1999 Jan 23; 129(3):77-9. PubMed ID: 10065510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
    Marrelli D, Caruso S, Pedrazzani C, Neri A, Fernandes E, Marini M, Pinto E, Roviello F.
    Am J Surg; 2009 Sep 23; 198(3):333-9. PubMed ID: 19375064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
    Hori H, Ajiki T, Fujita T, Okazaki T, Suzuki Y, Kuroda Y, Fujimori T.
    Jpn J Clin Oncol; 2006 Oct 23; 36(10):638-42. PubMed ID: 16908513
    [Abstract] [Full Text] [Related]

  • 12. Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases.
    Enjoji M, Yamaguchi K, Nakamuta M, Nakashima M, Kotoh K, Tanaka M, Nawata H, Watanabe T.
    Dig Liver Dis; 2004 Sep 23; 36(9):622-7. PubMed ID: 15460847
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The clinical significance of elevated levels of serum CA 19-9.
    Pavai S, Yap SF.
    Med J Malaysia; 2003 Dec 23; 58(5):667-72. PubMed ID: 15190651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A case of CA19-9 producing transitional cell carcinoma of the ureter].
    Yamamoto H, Ueda Y, Maruyama T, Kondou N, Nojima M, Takiuchi H, Mori Y, Shima H, Kubota A.
    Hinyokika Kiyo; 2003 Sep 23; 49(9):543-5. PubMed ID: 14598694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.